What is the current valuation of the Gene Panel Market as of 2025?

The Gene Panel Market valuation was 1421.53 USD Million in 2024. Read More

What is the projected market size for the Gene Panel Market by 2035?

The market is projected to reach 5848.51 USD Million by 2035. Read More

What is the expected CAGR for the Gene Panel Market during the forecast period 2025 - 2035?

The expected CAGR for the Gene Panel Market during this period is 13.72%. Read More

Which applications dominate the Gene Panel Market?

Oncology, with a valuation of 1745.0 USD Million, appears to be the leading application. Read More

What are the key technologies utilized in the Gene Panel Market?

Next Generation Sequencing, valued at 2500.0 USD Million, seems to be the most prominent technology. Read More

Who are the major players in the Gene Panel Market?

Key players include Illumina, Thermo Fisher Scientific, and Roche, among others. Read More

What are the primary end-use segments in the Gene Panel Market?

Hospitals, with a valuation of 2000.0 USD Million, represent a significant end-use segment. Read More

How do targeted and expanded gene panels compare in the market?

Both targeted and expanded gene panels are valued at 2400.0 USD Million, indicating equal market potential. Read More

What is the market valuation for panel tests compared to single gene tests?

Panel tests are valued at 2400.0 USD Million, whereas single gene tests are at 1200.0 USD Million. Read More

What role do diagnostic laboratories play in the Gene Panel Market?

Diagnostic laboratories are valued at 1600.0 USD Million, highlighting their crucial role in the market. Read More

Gene Panel Market

ID: MRFR/LS/4642-CR

220 Pages

Rahul Gotadki

Last Updated: March 28, 2026

Gene Panel Market Research Report Information By Technique (Amplicon Based Approach and Hybridization Based Approach) By Design (Predesigned Gene Panel and Customized Gene Panel) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Application (USD Million)
  1. 4.1.1 Oncology
  2. 4.1.2 Cardiology
  3. 4.1.3 Neurology
  4. 4.1.4 Infectious Disease
  5. 4.1.5 Pharmacogenomics
2. 4.2 Healthcare, BY Technology (USD Million)
  1. 4.2.1 Next Generation Sequencing
  2. 4.2.2 Polymerase Chain Reaction
  3. 4.2.3 Microarray
  4. 4.2.4 Sanger Sequencing
3. 4.3 Healthcare, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutions
  4. 4.3.4 Pharmaceutical Companies
4. 4.4 Healthcare, BY Product Type (USD Million)
  1. 4.4.1 Targeted Gene Panels
  2. 4.4.2 Expanded Gene Panels
  3. 4.4.3 Custom Gene Panels
5. 4.5 Healthcare, BY Test Type (USD Million)
  1. 4.5.1 Single Gene Tests
  2. 4.5.2 Panel Tests
  3. 4.5.3 Whole Exome Sequencing
6. 4.6 Healthcare, BY Region (USD Million)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Agilent Technologies (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Roche (CH)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 BGI Genomics (CN)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Myriad Genetics (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 PerkinElmer (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Fulgent Genetics (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Genomatix (DE)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY TECHNOLOGY
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 US MARKET ANALYSIS BY PRODUCT TYPE
7. 6.7 US MARKET ANALYSIS BY TEST TYPE
8. 6.8 CANADA MARKET ANALYSIS BY APPLICATION
9. 6.9 CANADA MARKET ANALYSIS BY TECHNOLOGY
10. 6.10 CANADA MARKET ANALYSIS BY END USE
11. 6.11 CANADA MARKET ANALYSIS BY PRODUCT TYPE
12. 6.12 CANADA MARKET ANALYSIS BY TEST TYPE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION
15. 6.15 GERMANY MARKET ANALYSIS BY TECHNOLOGY
16. 6.16 GERMANY MARKET ANALYSIS BY END USE
17. 6.17 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
18. 6.18 GERMANY MARKET ANALYSIS BY TEST TYPE
19. 6.19 UK MARKET ANALYSIS BY APPLICATION
20. 6.20 UK MARKET ANALYSIS BY TECHNOLOGY
21. 6.21 UK MARKET ANALYSIS BY END USE
22. 6.22 UK MARKET ANALYSIS BY PRODUCT TYPE
23. 6.23 UK MARKET ANALYSIS BY TEST TYPE
24. 6.24 FRANCE MARKET ANALYSIS BY APPLICATION
25. 6.25 FRANCE MARKET ANALYSIS BY TECHNOLOGY
26. 6.26 FRANCE MARKET ANALYSIS BY END USE
27. 6.27 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
28. 6.28 FRANCE MARKET ANALYSIS BY TEST TYPE
29. 6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
30. 6.30 RUSSIA MARKET ANALYSIS BY TECHNOLOGY
31. 6.31 RUSSIA MARKET ANALYSIS BY END USE
32. 6.32 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
33. 6.33 RUSSIA MARKET ANALYSIS BY TEST TYPE
34. 6.34 ITALY MARKET ANALYSIS BY APPLICATION
35. 6.35 ITALY MARKET ANALYSIS BY TECHNOLOGY
36. 6.36 ITALY MARKET ANALYSIS BY END USE
37. 6.37 ITALY MARKET ANALYSIS BY PRODUCT TYPE
38. 6.38 ITALY MARKET ANALYSIS BY TEST TYPE
39. 6.39 SPAIN MARKET ANALYSIS BY APPLICATION
40. 6.40 SPAIN MARKET ANALYSIS BY TECHNOLOGY
41. 6.41 SPAIN MARKET ANALYSIS BY END USE
42. 6.42 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
43. 6.43 SPAIN MARKET ANALYSIS BY TEST TYPE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY END USE
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY APPLICATION
51. 6.51 CHINA MARKET ANALYSIS BY TECHNOLOGY
52. 6.52 CHINA MARKET ANALYSIS BY END USE
53. 6.53 CHINA MARKET ANALYSIS BY PRODUCT TYPE
54. 6.54 CHINA MARKET ANALYSIS BY TEST TYPE
55. 6.55 INDIA MARKET ANALYSIS BY APPLICATION
56. 6.56 INDIA MARKET ANALYSIS BY TECHNOLOGY
57. 6.57 INDIA MARKET ANALYSIS BY END USE
58. 6.58 INDIA MARKET ANALYSIS BY PRODUCT TYPE
59. 6.59 INDIA MARKET ANALYSIS BY TEST TYPE
60. 6.60 JAPAN MARKET ANALYSIS BY APPLICATION
61. 6.61 JAPAN MARKET ANALYSIS BY TECHNOLOGY
62. 6.62 JAPAN MARKET ANALYSIS BY END USE
63. 6.63 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
64. 6.64 JAPAN MARKET ANALYSIS BY TEST TYPE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY END USE
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
70. 6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
71. 6.71 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY
72. 6.72 MALAYSIA MARKET ANALYSIS BY END USE
73. 6.73 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
74. 6.74 MALAYSIA MARKET ANALYSIS BY TEST TYPE
75. 6.75 THAILAND MARKET ANALYSIS BY APPLICATION
76. 6.76 THAILAND MARKET ANALYSIS BY TECHNOLOGY
77. 6.77 THAILAND MARKET ANALYSIS BY END USE
78. 6.78 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
79. 6.79 THAILAND MARKET ANALYSIS BY TEST TYPE
80. 6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
81. 6.81 INDONESIA MARKET ANALYSIS BY TECHNOLOGY
82. 6.82 INDONESIA MARKET ANALYSIS BY END USE
83. 6.83 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
84. 6.84 INDONESIA MARKET ANALYSIS BY TEST TYPE
85. 6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
86. 6.86 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY
87. 6.87 REST OF APAC MARKET ANALYSIS BY END USE
88. 6.88 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
89. 6.89 REST OF APAC MARKET ANALYSIS BY TEST TYPE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
92. 6.92 BRAZIL MARKET ANALYSIS BY TECHNOLOGY
93. 6.93 BRAZIL MARKET ANALYSIS BY END USE
94. 6.94 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
95. 6.95 BRAZIL MARKET ANALYSIS BY TEST TYPE
96. 6.96 MEXICO MARKET ANALYSIS BY APPLICATION
97. 6.97 MEXICO MARKET ANALYSIS BY TECHNOLOGY
98. 6.98 MEXICO MARKET ANALYSIS BY END USE
99. 6.99 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
100. 6.100 MEXICO MARKET ANALYSIS BY TEST TYPE
101. 6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
102. 6.102 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY
103. 6.103 ARGENTINA MARKET ANALYSIS BY END USE
104. 6.104 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
105. 6.105 ARGENTINA MARKET ANALYSIS BY TEST TYPE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY END USE
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY END USE
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
122. 6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
123. 6.123 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY
124. 6.124 REST OF MEA MARKET ANALYSIS BY END USE
125. 6.125 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
126. 6.126 REST OF MEA MARKET ANALYSIS BY TEST TYPE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
135. 6.135 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
137. 6.137 HEALTHCARE, BY END USE, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
139. 6.139 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Million)
141. 6.141 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Million)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.2.5 BY TEST TYPE, 2025-2035 (USD Million)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.3.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.3.3 BY END USE, 2025-2035 (USD Million)
  4. 7.3.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.3.5 BY TEST TYPE, 2025-2035 (USD Million)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.4.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.4.3 BY END USE, 2025-2035 (USD Million)
  4. 7.4.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.4.5 BY TEST TYPE, 2025-2035 (USD Million)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.5.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.5.3 BY END USE, 2025-2035 (USD Million)
  4. 7.5.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.5.5 BY TEST TYPE, 2025-2035 (USD Million)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.6.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.6.3 BY END USE, 2025-2035 (USD Million)
  4. 7.6.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.6.5 BY TEST TYPE, 2025-2035 (USD Million)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.7.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.7.3 BY END USE, 2025-2035 (USD Million)
  4. 7.7.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.7.5 BY TEST TYPE, 2025-2035 (USD Million)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.8.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.8.3 BY END USE, 2025-2035 (USD Million)
  4. 7.8.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.8.5 BY TEST TYPE, 2025-2035 (USD Million)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.9.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.9.3 BY END USE, 2025-2035 (USD Million)
  4. 7.9.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.9.5 BY TEST TYPE, 2025-2035 (USD Million)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.10.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.10.3 BY END USE, 2025-2035 (USD Million)
  4. 7.10.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.10.5 BY TEST TYPE, 2025-2035 (USD Million)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.11.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.11.3 BY END USE, 2025-2035 (USD Million)
  4. 7.11.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.11.5 BY TEST TYPE, 2025-2035 (USD Million)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.12.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.12.3 BY END USE, 2025-2035 (USD Million)
  4. 7.12.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.12.5 BY TEST TYPE, 2025-2035 (USD Million)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.13.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.13.3 BY END USE, 2025-2035 (USD Million)
  4. 7.13.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.13.5 BY TEST TYPE, 2025-2035 (USD Million)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.14.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.14.3 BY END USE, 2025-2035 (USD Million)
  4. 7.14.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.14.5 BY TEST TYPE, 2025-2035 (USD Million)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.15.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.15.3 BY END USE, 2025-2035 (USD Million)
  4. 7.15.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.15.5 BY TEST TYPE, 2025-2035 (USD Million)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.16.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.16.3 BY END USE, 2025-2035 (USD Million)
  4. 7.16.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.16.5 BY TEST TYPE, 2025-2035 (USD Million)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.17.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.17.3 BY END USE, 2025-2035 (USD Million)
  4. 7.17.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.17.5 BY TEST TYPE, 2025-2035 (USD Million)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.18.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.18.3 BY END USE, 2025-2035 (USD Million)
  4. 7.18.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.18.5 BY TEST TYPE, 2025-2035 (USD Million)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.19.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.19.3 BY END USE, 2025-2035 (USD Million)
  4. 7.19.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.19.5 BY TEST TYPE, 2025-2035 (USD Million)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.20.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.20.3 BY END USE, 2025-2035 (USD Million)
  4. 7.20.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.20.5 BY TEST TYPE, 2025-2035 (USD Million)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.21.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.21.3 BY END USE, 2025-2035 (USD Million)
  4. 7.21.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.21.5 BY TEST TYPE, 2025-2035 (USD Million)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.22.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.22.3 BY END USE, 2025-2035 (USD Million)
  4. 7.22.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.22.5 BY TEST TYPE, 2025-2035 (USD Million)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.23.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.23.3 BY END USE, 2025-2035 (USD Million)
  4. 7.23.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.23.5 BY TEST TYPE, 2025-2035 (USD Million)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.24.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.24.3 BY END USE, 2025-2035 (USD Million)
  4. 7.24.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.24.5 BY TEST TYPE, 2025-2035 (USD Million)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.25.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.25.3 BY END USE, 2025-2035 (USD Million)
  4. 7.25.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.25.5 BY TEST TYPE, 2025-2035 (USD Million)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.26.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.26.3 BY END USE, 2025-2035 (USD Million)
  4. 7.26.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.26.5 BY TEST TYPE, 2025-2035 (USD Million)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.27.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.27.3 BY END USE, 2025-2035 (USD Million)
  4. 7.27.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.27.5 BY TEST TYPE, 2025-2035 (USD Million)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.28.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.28.3 BY END USE, 2025-2035 (USD Million)
  4. 7.28.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.28.5 BY TEST TYPE, 2025-2035 (USD Million)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.29.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.29.3 BY END USE, 2025-2035 (USD Million)
  4. 7.29.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.29.5 BY TEST TYPE, 2025-2035 (USD Million)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.30.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.30.3 BY END USE, 2025-2035 (USD Million)
  4. 7.30.4 BY PRODUCT TYPE, 2025-2035 (USD Million)
  5. 7.30.5 BY TEST TYPE, 2025-2035 (USD Million)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Disease
Pharmacogenomics

Healthcare By Technology (USD Million, 2025-2035)

Next Generation Sequencing
Polymerase Chain Reaction
Microarray
Sanger Sequencing

Healthcare By End Use (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions
Pharmaceutical Companies

Healthcare By Product Type (USD Million, 2025-2035)

Targeted Gene Panels
Expanded Gene Panels
Custom Gene Panels

Healthcare By Test Type (USD Million, 2025-2035)

Single Gene Tests
Panel Tests
Whole Exome Sequencing

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”